Found: 5
Select item for more details and to access through your institution.
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1051, doi. 10.1007/s10637-022-01253-3
- By:
- Publication type:
- Article
A first-in-human dose-escalation study of the oral proteasome inhibitor oprozomib in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 2, p. 216, doi. 10.1007/s10637-016-0327-x
- By:
- Publication type:
- Article
Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3.
- Published in:
- Carcinogenesis, 2003, v. 24, n. 2, p. 291, doi. 10.1093/carcin/24.2.291
- By:
- Publication type:
- Article
A platform for oncogenomic reporting and interpretation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28348-y
- By:
- Publication type:
- Article
A Mechanistic Physiologically‐Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell Engagers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 457, doi. 10.1002/cpt.3056
- By:
- Publication type:
- Article